← Back to Clinical Trials
Recruiting NCT06823778

NCT06823778 Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation to Prevent Atrial Fibrillation After Cardiac Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06823778
Status Recruiting
Phase
Sponsor Vasily I. Kaleda
Condition Postoperative Atrial Fibrillation
Study Type INTERVENTIONAL
Enrollment 216 participants
Start Date 2025-02-17
Primary Completion 2027-09

Trial Parameters

Condition Postoperative Atrial Fibrillation
Sponsor Vasily I. Kaleda
Study Type INTERVENTIONAL
Phase N/A
Enrollment 216
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-02-17
Completion 2027-09
Interventions
Radiofrequency ablation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if an epicardial radiofrequency left atrial posterior wall isolation (box lesion ablation) prevents atrial fibrillation after cardiac surgery. The main question it aims to answer is: \- Does box lesion ablation lower the number of patients experiencing de-novo atrial fibrillation requiring any treatment after cardiac surgery? Researchers will compare box lesion ablation to no ablation to see if ablation prevents postoperative atrial fibrillation. Participants will undergo ablation or no ablation at the time of other cardiac surgery. Data will be collected while in hospital. Additional information will be collected on 30th day after surgery by telephone call or during a visit.

Eligibility Criteria

Inclusion Criteria: * All patients undergoing cardiac surgery by a single surgeon (V.K.) * Informed consent Exclusion Criteria: * History of atrial fibrillation/flutter * Minimally invasive approach * Off-pump surgery * Emergent/salvage surgery * Severe pericardial adhesions

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology